According to a new report, published by KBV research, The Global Coronary Artery Bypass Graft Market size is expected to reach $20.6 billion by 2029, rising at a market growth of 9.0% CAGR during the forecast period.
The Double CABG Surgery segment is showcasing a CAGR of 9.3% during (2023 - 2029). Double bypass surgery is a form of open-heart procedure that reroutes blood around two coronary arteries that are either completely or partially obstructed in the heart. An artery from another area of the body must be harvested in order to perform it. To get around the obstruction and restart blood flow, the artery is then grafted into the heart.
The Off-pump segment is leading the Global Coronary Artery Bypass Graft Market by Method in 2022 thereby, achieving a market value of $11.6 billion by 2029. The increase in popularity is attributable to the advantages of the procedure, including fewer hospital days, smaller incisions, and quicker healing. It also lowers the risk of several postoperative problems, including arrhythmia, infection, infection, and inflammation. Additionally, it gives individuals with kidney issues, chronic lung ailments, and cirrhosis better options.
The Cardiology Centers segment has shown the high growth rate of 9.2% during (2023 - 2029). Growing public awareness of the benefits of CABG surgery in addressing severe coronary artery problems and increasing demand for specialized cardiac care are two factors predicted to propel the segment's revenue growth. The ability to perform complex CABG procedures in specialized cardiac facilities has also been made possible by advancements in medical technology and surgical techniques, which are anticipated to fuel the segment's revenue growth.
The North America segment dominated the Global Coronary Artery Bypass Graft Market by Region in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $8.9 billion by 2029. The is exhibiting a CAGR of 8.6% during (2023 - 2029). Additionally, The Asia Pacific market would showcase a CAGR of 10% during (2023 - 2029).
Full Report: https://www.kbvresearch.com/coronary-artery-bypass-graft-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Terumo Corporation, Karl Storz SE & Co. KG, Edwards Lifesciences Corporation, Johnson & Johnson (Ethicon, Inc.), Boston Scientific Corporation, Stryker Corporation, LivaNova PLC, Genesee BioMedical, Inc., and Vitalitec International Medizintechnik GmbH (Peters Surgical).
By Procedure
By Method
By End-use
By Geography
Companies Profiled
Unique Offerings 
